Optiver Holding
TXG icon

Optiver Holding’s 10x Genomics TXG Stock Holding History

Optiver Holding’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5K Buy
456
+392
+613% +$10.3K ﹤0.01% 1573
2026
Q1 		$1.36K Sell
64
-6
-9% -$120 ﹤0.01% 1990
2025
Q4 		$1.14K Sell
70
-732
-91% -$11.1K ﹤0.01% 2193
2025
Q3 		$9.38K Buy
802
+568
+243% +$7.41K ﹤0.01% 1342
2025
Q2 		$2.71K Buy
+234
New +$2.13K ﹤0.01% 1319
2024
Q3 		– Sell
-121
Closed -$2.35K – 1102
2024
Q2 		$2.35K Buy
+121
New +$3.17K ﹤0.01% 840

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optiver Holding's TXG Position: Q2 2026 in Review

Optiver Holding increased its 10x Genomics (TXG) stake by 613% in Q2 2026, buying an estimated $10.3K and bringing the position to 456 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Optiver Holding first reported a position in TXG in Q2 2024 and has held it in 6 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Optiver Holding held 456 shares of 10x Genomics worth $17.5K as of Q2 2026.
  • Optiver Holding bought 392 10x Genomics shares in Q2 2026, an estimated $10.3K.
  • 10x Genomics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1573 holding.
  • Optiver Holding first reported a position in 10x Genomics in Q2 2024 and has held it in 6 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.